These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 19647614)
21. [Peritoneal carcinomatosis of colorectal cancer: cytoreductive surgery and hyperthermic intraperitoneal chemotherapy]. Königsrainer I; Beckert S; Brücher B; Zieker D; Königsrainer A Dtsch Med Wochenschr; 2011 Sep; 136(36):1811-4. PubMed ID: 21882140 [TBL] [Abstract][Full Text] [Related]
22. [Recurrent Peritoneal Metastases after Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Colorectal Cancer]. Königsrainer I; Struller F; Zieker D; Königsrainer A; Beckert S Zentralbl Chir; 2015 Dec; 140(6):607-9. PubMed ID: 23846542 [TBL] [Abstract][Full Text] [Related]
23. Angiogenesis-Related Markers and Prognosis After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Metastatic Colorectal Cancer. de Cuba EM; de Hingh IH; Sluiter NR; Kwakman R; Coupé VM; Beliën JA; Verwaal VJ; Meijerink WJ; Delis-van Diemen PM; Bonjer HJ; Meijer GA; Te Velde EA Ann Surg Oncol; 2016 May; 23(5):1601-8. PubMed ID: 26727921 [TBL] [Abstract][Full Text] [Related]
24. Cytoreduction and hyperthermic intraperitoneal chemotherapy: a feasible and effective option for colorectal cancer patients after emergency surgery in the presence of peritoneal carcinomatosis. van Oudheusden TR; Braam HJ; Nienhuijs SW; Wiezer MJ; van Ramshorst B; Luyer MD; Lemmens VE; de Hingh IH Ann Surg Oncol; 2014 Aug; 21(8):2621-6. PubMed ID: 24671638 [TBL] [Abstract][Full Text] [Related]
25. A critical look at local-regional management of peritoneal metastasis. Chan CH; Cusack JC; Ryan DP Hematol Oncol Clin North Am; 2015 Feb; 29(1):153-8. PubMed ID: 25475577 [TBL] [Abstract][Full Text] [Related]
26. Cost Effectiveness of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Management of Colorectal Peritoneal Carcinomatosis. Lee ZJ; Chia SL; Tan G; Soo KC; Teo CCM Ann Surg Oncol; 2018 Aug; 25(8):2340-2346. PubMed ID: 29948417 [TBL] [Abstract][Full Text] [Related]
27. P.R.O.P.S. - A novel Pre-Operative Predictive Score for unresectability in patients with colorectal peritoneal metastases being considered for cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC). Yong ZZ; Tan GHC; Shannon N; Chia C; Teo MCC World J Surg Oncol; 2019 Aug; 17(1):138. PubMed ID: 31391066 [TBL] [Abstract][Full Text] [Related]
28. Perioperative Systemic Chemotherapy, Cytoreductive Surgery, and Hyperthermic Intraperitoneal Chemotherapy in Patients With Colorectal Peritoneal Metastasis: Results of the Prospective Multicenter Phase 2 COMBATAC Trial. Glockzin G; Zeman F; Croner RS; Königsrainer A; Pelz J; Ströhlein MA; Rau B; Arnold D; Koller M; Schlitt HJ; Piso P Clin Colorectal Cancer; 2018 Dec; 17(4):285-296. PubMed ID: 30131226 [TBL] [Abstract][Full Text] [Related]
29. Does Primary Tumor Side Matter in Patients with Metastatic Colon Cancer Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy? Kelly KJ; Alsayadnasser M; Vaida F; Veerapong J; Baumgartner JM; Patel S; Ahmad S; Barone R; Lowy AM Ann Surg Oncol; 2019 May; 26(5):1421-1427. PubMed ID: 30815802 [TBL] [Abstract][Full Text] [Related]
30. Repeat Cytoreductive Surgery-Hyperthermic Intraperitoneal Chemoperfusion is Feasible and Offers Survival Benefit in Select Patients with Peritoneal Metastases. Choudry HA; Bednar F; Shuai Y; Jones HL; Pai RK; Pingpank JF; Ahrendt SS; Holtzman MP; Zeh HJ; Bartlett DL Ann Surg Oncol; 2019 May; 26(5):1445-1453. PubMed ID: 30825033 [TBL] [Abstract][Full Text] [Related]
31. Cytoreductive surgery and hyperthermic intra-peritoneal chemotherapy treatment of colorectal peritoneal metastases: cohort analysis of high volume disease and cure rate. Cashin PH; Dranichnikov F; Mahteme H J Surg Oncol; 2014 Aug; 110(2):203-6. PubMed ID: 24846340 [TBL] [Abstract][Full Text] [Related]
32. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in Asian patients: 100 consecutive patients in a single institution. Teo MC; Tan GH; Tham CK; Lim C; Soo KC Ann Surg Oncol; 2013 Sep; 20(9):2968-74. PubMed ID: 23504144 [TBL] [Abstract][Full Text] [Related]
33. Strategies for Managing Intraoperative Discovery of Limited Colorectal Peritoneal Metastases. Mariani A; Gelli M; Sourrouille I; Benhaim L; Faron M; Honoré C; Elias D; Goéré D Ann Surg Oncol; 2019 May; 26(5):1437-1444. PubMed ID: 30805806 [TBL] [Abstract][Full Text] [Related]
34. Is advanced age a hesitation for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in colorectal cancer? Cigdem Arslan N; Bisgin T; Altay C; Yavuzsen T; Karaoglu A; Canda AE; Sarioglu S; Sokmen S J BUON; 2018 Dec; 23(7):77-83. PubMed ID: 30722115 [TBL] [Abstract][Full Text] [Related]
35. Predictors of progression in high-grade appendiceal or colorectal peritoneal carcinomatosis after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Baumgartner JM; Tobin L; Heavey SF; Kelly KJ; Roeland EJ; Lowy AM Ann Surg Oncol; 2015 May; 22(5):1716-21. PubMed ID: 25145504 [TBL] [Abstract][Full Text] [Related]
36. Neoadjuvant chemotherapy with bevacizumab may improve outcome after cytoreduction and hyperthermic intraperitoneal chemoperfusion (HIPEC) for colorectal carcinomatosis. Ceelen W; Van Nieuwenhove Y; Putte DV; Pattyn P Ann Surg Oncol; 2014 Sep; 21(9):3023-8. PubMed ID: 24756812 [TBL] [Abstract][Full Text] [Related]
37. The American Society of Peritoneal Surface Malignancies (ASPSM) Multiinstitution Evaluation of the Peritoneal Surface Disease Severity Score (PSDSS) in 1,013 Patients with Colorectal Cancer with Peritoneal Carcinomatosis. Esquivel J; Lowy AM; Markman M; Chua T; Pelz J; Baratti D; Baumgartner JM; Berri R; Bretcha-Boix P; Deraco M; Flores-Ayala G; Glehen O; Gomez-Portilla A; González-Moreno S; Goodman M; Halkia E; Kusamura S; Moller M; Passot G; Pocard M; Salti G; Sardi A; Senthil M; Spilioitis J; Torres-Melero J; Turaga K; Trout R Ann Surg Oncol; 2014 Dec; 21(13):4195-201. PubMed ID: 24854493 [TBL] [Abstract][Full Text] [Related]
38. Effect of a concomitant urologic procedure on outcomes following cytoreductive surgery with hyperthermic intraperitoneal chemotherapy. Lyon TD; Turner Ii RM; Nikonow TN; Wang L; Uy J; Ramalingam L; Holtzman MP; Pingpank JF; Bartlett DL; Davies BJ J Surg Oncol; 2016 Feb; 113(2):218-22. PubMed ID: 26775909 [TBL] [Abstract][Full Text] [Related]
39. Pathological response to neoadjuvant chemotherapy: a new prognosis tool for the curative management of peritoneal colorectal carcinomatosis. Passot G; You B; Boschetti G; Fontaine J; Isaac S; Decullier E; Maurice C; Vaudoyer D; Gilly FN; Cotte E; Glehen O Ann Surg Oncol; 2014 Aug; 21(8):2608-14. PubMed ID: 24668148 [TBL] [Abstract][Full Text] [Related]
40. [Combined cytoreductive surgery and intraoperative hyperthermic chemo-perfusion for peritoneal carcinomatosis: methods, postoperative features and end results]. Tarasov VA; Vinogradova MV; Norbaev ShE; Sharov IuK; Stavrovietskiĭ VV; Adueva SA; Blium MB Vopr Onkol; 2006; 52(6):638-42. PubMed ID: 17338240 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]